Unknown NA INTERVENTIONAL 4-arm NCT02955641

Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy

Sponsor: Sheba Medical Center

Conditions Glaucoma, Angle-Closure Glaucoma, Closed-Angle Glaucoma, Narrow-Angle

Interventions Dexamethasone Disodium Phosphate 0.1% Hydroxyethylcellulose 0.19% Nepafenac 0.1%

Updated 8 times since 2017 Last updated: Apr 23, 2018 Started: Nov 1, 2016 Primary completion: Nov 30, 2018 Completion: Nov 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02955641, this NA trial focuses on Glaucoma, Angle-Closure and Glaucoma, Closed-Angle and remains ongoing. Sponsored by Sheba Medical Center, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
May 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — May 2020 [monthly]

Recruiting NA
May 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2017 — May 2018 [monthly]

Not Yet Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sheba Medical Center

Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Litwinsky, Israel